BCAX Competitors & Alternatives
Compare Bicara Therapeutics Inc. Common Stock with similar stocks in the same industry
Biotechnology
BCAX
Main Stock$28.15
Tradestie Score
64
Market Cap
$906.29M
Analyst Upside
+11.8%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NTLA
Intellia Therapeutics, Inc
|
$13.02
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$37.46
|
$1.97B | - | 60 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.88
|
$1.92B | - | 63 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$103.79
|
$1.92B | - | 58 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$71.21
|
$1.90B | 458.4 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$41.50
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.49
|
$1.81B | - | 62 | Compare |
|
MPLT
MPLT
|
$36.57
|
$1.78B | - | 63 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.52
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$23.64
|
$1.78B | - | 63 | Compare |
More BCAX Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry